Pediatric high-grade glioma: aberrant epigenetics and kinase signaling define emerging therapeutic opportunities is a research paper published in Journal of Neuro-Oncology (2020). On theSindex it has a DataRank of 0. It has been cited 16 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: NS093387
National Institutes of Health
Grant: R61 NS NS111058
National Institutes of Health
Grant: P50 CA127001
NINDS NIH HHS
Grant: R21 NS093387
NINDS NIH HHS
Grant: R33 NS111058
NINDS NIH HHS
Grant: R61 NS111058
NCI NIH HHS
Grant: P30 CA016672
National Institutes of Health
Grant: 3P50CA127001-10S1
SPORE in Brain Cancer
National Institutes of Health
Grant: 4R33NS111058-02
Evaluation of Novel Dually Targeted Kinase Inhibitors for Therapy of Adult and Pediatric High-Grade Glioma
National Institutes of Health
Grant: 1R21NS093387-01
Preclinical evaluation of a novel combinatory epigenetics based therapy for glioblastoma
FWCI
0.90
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals